Next 10 |
home / stock / prvcf / prvcf news
2024-05-03 03:06:49 ET More on PreveCeutical Medical Inc. Financial information for PreveCeutical Medical Inc. Read the full article on Seeking Alpha For further details see: PreveCeutical announces management cease trade order
Vancouver, British Columbia--(Newsfile Corp. - May 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the " Company " or " PreveCeutical ") announces that the Company has missed the filing deadline of April 29, 2024 to file the Company's audited annual financ...
2023-12-04 10:00:34 ET %Obesity and diabetes have become a problem for developed world countries. To address the global rise of these issues, this company is pursuing a dual-gene therapy strategy using proprietary bionanotechnological approaches. The rational design of tissue-targeted b...
PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM Canada NewsWire ...
PreveCeutical Medical Inc (PRVCF) is expected to report for Q1 2024
PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of...
PreveCeutical Showcases Dynamic Evolution in AI Strategy Canada NewsWire VANCOUVER, BC , Sept. 12, 2023 /CNW/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), PreveCeutical Medical Inc. marks today as an i...
PreveCeutical Engages New to the Street for Production & Broadcasting Services PreveCeutical Engages New to the Street for Production & Broadcasting Services Canada NewsWire VANCOUVER, BC , Aug. 31, 2023 /CNW/ - PreveCeutical Medical Inc. (the "Comp...
PreveCeutical Files Cyclic Peptides And Uses Thereof in the EU and Australia Canada NewsWire VANCOUVER, BC , July 24, 2023 /CNW/ - PreveCeutica l Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to anno...
Vancouver, British Columbia--(Newsfile Corp. - June 28, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") , is pleased to announce that PreveCeutical is furthering the progress of two of its patent families. The patent family...
News, Short Squeeze, Breakout and More Instantly...
PreveCeutical Medical Inc Company Name:
PRVCF Stock Symbol:
OTCMKTS Market:
Vancouver, British Columbia--(Newsfile Corp. - May 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the " Company " or " PreveCeutical ") announces that the Company has missed the filing deadline of April 29, 2024 to file the Company's audited annual financ...
2023-12-04 10:00:34 ET %Obesity and diabetes have become a problem for developed world countries. To address the global rise of these issues, this company is pursuing a dual-gene therapy strategy using proprietary bionanotechnological approaches. The rational design of tissue-targeted b...
PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM Canada NewsWire ...